Literature DB >> 20466391

[Recommendations for the study and evaluation of gender differences in clinical trials in Spain].

Elisa Chilet Rosell1, M Teresa Ruiz Cantero, Noa Laguna-Goya, Fernando De Andrés Rodriguez-Trelles.   

Abstract

Mesh：

Year:  2010        PMID： 20466391     DOI： 10.1016/j.medcli.2010.03.018

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  2 in total

1.  Sex as a variable in medicines assessment reports for licensing in the European Union. Can gender bias be excluded?

Authors:  N Laguna-Goya; F de Andres-Trelles
Journal:  Eur J Clin Pharmacol       Date:  2014-02-11       Impact factor: 2.953

Review 2.  Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs.

Authors:  Elisa Chilet-Rosell
Journal:  Glob Health Action       Date:  2014-12-09       Impact factor: 2.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.